Verily has been granted FDA approval for its prescription-only smartwatch. The company is working with the Food and Drug Administration to develop a smart contact lens that can be used by people who have lost their sight or are blind in one eye. The company, a subsidiary of Alphabet, first launched the product two years ago and it has since been used in a number of studies by the company. The technology aims to provide detailed forms of health data that can create better-informed electronic health records. The announcement follows similar FDA approval for an ECG feature in the Apple Watch, which was granted in September.
Verily has been granted FDA approval for its prescription-only smartwatch. The device, called the Verily Study Watch, records and displays a user's electrocardiogram (ECG) rhythms. The company, a subsidiary of Alphabet, first launched the product two years ago and it has since been used in a number of studies by the company. The technology aims to provide detailed forms of health data that can create better-informed electronic health records. The announcement follows similar FDA approval for an ECG feature in the Apple Watch, which was granted in September.